Phosphatidylinositol Kinase (PIK)

Phosphatidylinositol kinases are a family of enzymes that phosphorylate phosphatidylinositol (PI) and its derivatives at specific positions on the inositol ring, playing central roles in cell signaling, membrane trafficking, and various physiological processes. The two main subtypes are phosphatidylinositol 3-kinases (PI3Ks) and phosphatidylinositol 4-kinases (PI4Ks), each with distinct substrate specificity and biological functions. PI3Ks catalyze phosphorylation at the D-3 position of PI lipids, generating key signaling molecules like PtdIns(3)P, PtdIns(3,4)P₂, and PtdIns(3,4,5)P₃. These products serve as docking sites for proteins containing pleckstrin homology (PH), PX, or FYVE domains—recruiting them to membranes to propagate intracellular signals involved in cell growth, proliferation, survival, motility, metabolism and more. PI4Ks phosphorylate at the D‑4 position to produce phosphatidylinositol 4-phosphate (PI(4)P), which is a precursor for further phosphorylation events leading to important secondary messengers like PIP₂ and subsequently PIP₃. These lipids regulate processes such as membrane trafficking/cytokinesis/organelle identity. Aberrant activity or regulation of these kinases contributes to pathologies including cancer, immunodeficiencies, and diabetes. Targeting these enzymes has become a major focus area for drug development efforts across oncology/immunology/metabolic disease fields.

Other names

Phosphoinositide KinasePI Kinase

Inhibition of phosphatidylinositol kinase activity, blocking downstream signaling pathways.